Literature DB >> 20400141

Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.

Brian H Eisner1, Sima P Porten, Seth K Bechis, Marshall L Stoller.   

Abstract

PURPOSE: The epidemiological relationship between nephrolithiasis and type 2 diabetes mellitus is well-known. Patients with diabetes mellitus are at increased risk for nephrolithiasis and those with nephrolithiasis are at risk for diabetes mellitus. We examined 24-hour urine composition in stone formers with and without diabetes mellitus.
MATERIALS AND METHODS: We retrospectively reviewed a database of 462 stone forming patients to examine the relationship between hypertension and 24-hour urine composition. Multivariate linear regression models were adjusted for age, race, gender, body mass index, hypertension, relevant medications and 24-hour urine constituents.
RESULTS: On univariate analysis diabetic patients had significantly greater urine volume than nondiabetic patients (2.5 vs 2.1 l daily, p = 0.004). Those with diabetes mellitus also excreted less daily potassium (61.1 vs 68.8 mEq, p = 0.04), phosphate (0.84 vs 1.0 gm, p = 0.002) and creatinine (1405.5 vs 1562.8 mg, p = 0.03), and had significantly lower daily urine pH (5.78 vs 6.09, p <0.001) and CaP supersaturation (0.49 vs 1.20, p <0.001) than nondiabetic patients. On multivariate analysis compared to patients without diabetes mellitus those with type II diabetes mellitus had significantly lower urine pH (-0.34, 95% CI -0.48 to -0.21) and significantly greater urine oxalate (6.43 mg daily, 95% CI 1.26 to 11.60) and volume (0.38 l daily, 95% CI 0.13 to 0.64).
CONCLUSIONS: Results show that of stone formers patients with type II diabetes mellitus excrete significantly greater urinary oxalate and significantly lower urine pH than those without diabetes mellitus. These findings are important for treating nephrolithiasis since they may influence dietary counseling, medical management and stone prevention. Copyright 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400141     DOI: 10.1016/j.juro.2010.02.007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  44 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

2.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

3.  Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells.

Authors:  Donna Arvans; Yong-Chul Jung; Dionysios Antonopoulos; Jason Koval; Ignacio Granja; Mohamed Bashir; Eltayeb Karrar; Jayanta Roy-Chowdhury; Mark Musch; John Asplin; Eugene Chang; Hatim Hassan
Journal:  J Am Soc Nephrol       Date:  2016-10-13       Impact factor: 10.121

4.  Association with meteo-climatological factors and daily emergency visits for renal colic and urinary calculi in Cuneo, Italy. A retrospective observational study, 2007-2010.

Authors:  Vincenzo Condemi; Massimo Gestro; Elena Dozio; Bruno Tartaglino; Massimiliano Marco Corsi Romanelli; Umberto Solimene; Roberto Meco
Journal:  Int J Biometeorol       Date:  2014-06-27       Impact factor: 3.787

Review 5.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

6.  Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network.

Authors:  Michelle R Denburg; Mary B Leonard; Kevin Haynes; Shamir Tuchman; Gregory Tasian; Justine Shults; Lawrence Copelovitch
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

7.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

Review 8.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Association of urolithiasis with systemic conditions among pediatric patients at children's hospitals.

Authors:  Paul J Kokorowski; Jonathan C Routh; Katherine C Hubert; Dionne A Graham; Caleb P Nelson
Journal:  J Urol       Date:  2012-08-18       Impact factor: 7.450

10.  Diabetic severity and risk of kidney stone disease.

Authors:  Aviva E Weinberg; Chirag J Patel; Glenn M Chertow; John T Leppert
Journal:  Eur Urol       Date:  2013-03-17       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.